AI assistant
Sending…
Anterix Inc. — Director's Dealing 2022
Nov 10, 2022
33018_dirs_2022-11-09_74569b74-d194-4037-afc8-475e5b5ff441.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2022-11-08
Reporting Person: Ashe Gena L (Chief Legal Officer & Corp Sec)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-08 | Common Stock | S | 920 | $36.904 | Disposed | 32871 | Direct |
Footnotes
F1: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $36.9026 to $36.97. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
More from Anterix Inc.
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Feb 11
Interim / Quarterly Report
2026
Feb 11
Regulatory Filings
2026
Feb 2
Major Shareholding Notification
2026
Jan 30
Regulatory Filings
2026
Jan 7
Director's Dealing
2025
Dec 19